Morepen Laboratories LimitedNSE: MOREPENLAB

Morepen Laboratories Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Morepen hits record Q2 revenue of Rs. 755 Cr; EBITDA surges 273% to Rs. 132 Cr; CDMO momentum drives Morepen into a new earnings scale; H1 EBITDA reaches Rs. 220 Cr".

· Issued by Morepen Laboratories Limited via NSE India

Filed with NSE · ISIN INE083A01026 ·

On 6ix: 6ix.com/news/morepen-laboratories-limited-has-informed-the-exchange-regarding-a-press-release-dated-october-27-2026-titled-morepen-hits-record-q2-revenue-of-rs-755-cr-ebitda-surges-273percent-to-rs-132-cr-cdmo-momentum-drives-morepen-into-a-new-earnings-scale-h1-ebitda-reaches-rs-220-cr

Morepen Laboratories Limited

View Attachment

6ix is reading this filing.

View original source (NSE India)Morepen Laboratories Limited on 6ix

In the deck

Earlier from Morepen Laboratories

All Morepen Laboratories news releases